CClinicalTrials.gg
Not yet recruitingNCT06806748GRASUpdated Feb 4, 2025

Gait Recovery After Stroke

An observational study in Stroke, sponsored by University of Strathclyde. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-04.

Sponsored by University of Strathclyde · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
36
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this observational study is to track the recovery of stance duration symmetry during the first 6 months after stroke using wearable sensors and explore the influence of stroke specific factors (time since stroke, stroke type, location and paretic side).

Read the detailed description

Gait impairments can limit the ability to perform daily activities and increase the risk of falls in stroke survivors. Although rehabilitation improves walking in people with stroke, it is unclear whether the improvement relies on compensatory strategies or can be further improved to achieve normal or closer to normal performance.

Stance duration symmetry is an ideal measure of gait recovery in stroke survivors as it indicates the paretic sides capacity to control body weight and maintain balance during walking. Measuring stance duration symmetry may, therefore, be useful for monitoring gait recovery and could be considered as one of key goals in stroke rehabilitation.

Understanding the mechanisms of gait recovery in people with stroke is, therefore, essential for designing treatment program, setting realistic goals and appropriate timing for promoted intervention according to their stroke characteristics.

Our plan is to track changes in the symmetry of stance duration of hemiplegic patients during the first 6 months after stroke attached at the following time points: 1) at recruitment (within 2 weeks after of stroke), 2) 4th weeks (1 month) after stroke, 3) 12th weeks (3 months) after stroke, and 4) 26th weeks (6 months) after stroke. Two wearable accelerometers (the ActivPAL4+, PAL technology, Glasgow, UK) directly to the skin of both anterior thighs using sticky pads for 4 days (24 hours) period. Demographic (age and gender) and relevant clinical data (10-meter walk test, Modified Rivermead Mobility Index (RMI), stroke type, paretic side) will also be recorded as factors to explain gait symmetry.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • Observational, gait, symmetry
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 36 is below the median of 160 across 1,692 observational studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Strathclyde is the lead sponsor of 19 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Sub-acute stroke patients with hemiplegia who are referred for rehabilitation

Inclusion criteria

  • aged 18 or older
  • diagnosis of a first occurrence of stroke by consultant stroke physician
  • Medically stable
  • referred for rehabilitation
  • functional ambulatory category of 1 and over

Exclusion criteria

Exclusion Criteria:

  • acute skin condition
  • transient ischemic stroke
  • comorbidities that may interfere with walking function, such as Parkinson's disease or lower limb amputation
  • severe communication impairments or delirium
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
36 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Gait symmetry

    Gait symmetry will be measured from the signals produced by two thigh mounted inertial motion units. The variable of prime interest is the difference in stance duration between the hemiplegic and non-hemiplegic sides

    Time frame: From enrollment to 6 months

Secondary outcomes

  1. Rivermead Mobility Index

    Standard, patient reported outcome measure of mobility

    Time frame: From enrollment to 6 months

  2. Ten meter walk test

    Time it takes to walk 10 m. This is a well used, standardized objective test of mobility

    Time frame: From enrollment to 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06806748
Lead sponsor
University of Strathclyde
Responsible party
Sponsor
First posted
Feb 4, 2025
Start date
Aug 1, 2025 (estimated)
Primary completion
Feb 1, 2027 (estimated)
Completion
May 10, 2027 (estimated)
Last update
Feb 4, 2025

Study contacts

Andrew Kerr, PhD
Contact
a.kerr@strath.ac.uk
+44 141 548 2855 ext. 2855
Janeesata Kuntapun, MSc
Contact
janeesata.kuntapun.2022@strath.ac.uk
+44 141 548 0000 ext. 0000
Andrew Kerr, Ph.D
principal investigator · University of Strathclyde

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion